NADİR HASTALIKLARIN AİLELER ÜZERİNDEKİ PSİKO-SOSYAL, FİZİKSEL VE EKONOMİK ETKİLERİ
Nadir hastalıklar, nüfusun geneline oranla daha az sayıda insanda görülen (1/2000 ve daha az kişide) hastalıkları ifade
etmektedir. Nadir hastalıklar ciddi, kronik, ilerleyici ve yıpratıcı özelliklere sahip olmakla birlikte bir çok hastalık için tıbbi ve
bilimsel bilgi eksikliği mevcuttur, yeterli-uygun tedavi seçenekleri bulunmamaktadır. Tüm bu özellikleri taşıyan bir hastalığa
sahip olmanın hem hasta hem de ailesi üzerinde psiko-sosyal, fiziksel ve ekonomik etkileri bulunmaktadır.
Nadir hastalığa sahip bir bireyin ailesi olmak, hastalık sürecinin etkilerini doğrudan ve dolaylı olarak yaşamak anlamına
gelmektedir. Fiziksel olarak aileler hastalığın tanı ve tedavi sürecinde kilo kaybı, iştahsızlık, yorgunluk, uyku problemleri gibi
bir çok fiziksel etkiyi yaşamaktadırlar. Psikolojik olarak aile içinde teşhis süreci çok uzun, tedavi olanakları kısıtlı ya da olmayan
nadir bir hastalığın bulunması, aile üyeleri için depresyon, kaygı, korku, kızgınlık, şüphe, belirsizlik gibi bir çok sonuca yol
açmaktadır. Sosyal açıdan arkadaş sayılarının azalmasına, sosyal destek mekanizmalarının zayıflamasına ve sosyal olarak
toplumdan izole hissetmelerine neden olmaktadır. Ailelerin yaşadığı en görünür etkilerden olan ekonomik etkiler konusunda
ise aileler, teşhis ve tedavi imkanlarına erişim güçlüğü, işgücü kaybı gibi kendilerini ekonomik olarak baskılayacak bir çok farklı
etkiye maruz kalmaktadırlar. Bu çalışmanın amacı, nadir bir hastalığa sahip olmanın aile üzerindeki psiko-sosyal, fiziksel ve
ekonomik etkilerini tartışmaktır.
___
- 1. Anderson, M., Elliott, E. J., Zurynski, Y. A. (2013). Australian families living with rare disease: experiences
of diagnosis, health services use and needs for psychosocial support. Orphanet Journal of Rare Diseases,
8(1), 22. http://doi.org/10.1186/1750-1172-8-22.
- 2. Brewer, H., Eatough, V., Smith, J.A., Stanley, C.A., Glendinning, N.W., Quarrell, O.W.J. (2008). The
impact of juvenile Huntington's disease on the family: the case of a rare childhood condition. Journal
of Health Psychology, 13, 5-16, https://doi.org/10.1177/1359105307084307.
- 3. Brown, K.A.E., Barbarin, O.A. (1996). Gender differences in parenting a child with cancer. Social Work
in Health Care, 22(4), 53-71. https://doi.org/10.1300/J010v22n04_04.
- 4. Burke, S. O., Costello, E. A., Handley-Derry, M., Kauffmann, E., Dillon, M., (1997). Stress-point
preparation for parents of repeatedly hospitalized children with chronic conditions. Research in Nursing
and Health, 20, 475-485. |https://doi.org/10.1002/(SICI)1098-240X(199712)20:6<475::AIDNUR2>
3.0.CO;2-J.
- 5. Burke, S. O., Kauffmann, E. C., Harrison, M. B., Wiskin, N., (1999). Assessment of stressors in families
with a child who has a chronic condition. Maternal Child Nursing, 24, 98–106.
- 6. Dharssi, S., Wong-Rieqer, D., Harold, M., Terry, S. (2017). Review of 11 national policies for rare diseases
in the context of key patient needs. Orphanet Journal of Rare Diseases, 12 (1) 63- 76.
http://doi.org/10.1186/s13023-017-0618-0.
- 7. Doğuç, E. (2017). Yetim ilaçların (orphan drugs-nadir hastalıklarda kullanılan ilaçlar) Türkiye’de ve
dünyadaki durumu. Sağlık Akademisyenleri Dergisi, 4 (3), 196-201. http://doi.org/10.5455/sad.13-
1502288229.
- 8. Dündar, M., Karabulut, S. Y. (2010). Türkiye’de nadir hastalıklar ve yetim ilaçlar; Medikal ve sosyal
problemler. Erciyes Tıp Dergisi, 32(3):195-200.
- 9. Eatough, V., Santini, H., Eiser, C., Goller, M.-L., Krysa, W., de Nicola, A., … Smith, J. A. (2013). The
personal experience of parenting a child with Juvenile Huntington’s Disease: perceptions across.
Europe. European Journal of Human Genetics, 21(10), 1042–1048.
http://doi.org/10.1038/ejhg.2013.15.
- 10. Enskar, K., Carlsson, M., Golsater, M., Hamrin, E., Kreuger, A. (1997). Parental reports of changes and
challenges that result from parenting a child with cancer. Journal of Pediatric Oncology Nursing, 14,
156–163. https://doi.org/10.1016/S1043-4542(97)90051-5.
- 11. Eurordis. (2009). The voice of 12,000 patients: experiences and expectations of rare disease: Patients
on diagnosis and care in Europe. Erişim Tarihi: 12 Şubat 2017,
https://www.eurordis.org/IMG/pdf/voice_12000_patients/EURORDISCARE_FULLBOOKr.pdf.
- 12. Eurordis. (2017). Juggling care and daily life: The balancing act of the rare disease community. Erişim
Tarihi: 5 Aralık 2017,
http://download2.eurordis.org.s3.amazonaws.com/rbv/2017_05_09_Social%20survey%20leaflet%20
final.pdf.
92
- 13. Ferrell, B.R., Rhiner, M., Shapiro, B., Dierkes, M. (1994). The experience of pediatric cancer pain, part I:
Impact of pain on the family. Journal of Pediatric Nursing, 9, 368–379.
- 14. Fields, A. I., Rosenblatt, A., Pollack, M. M., Kaufman, J. (1991). Home care cost-effectiveness for
respiratory technology-dependent children. American Journal of Diseases of Children, 145(7), 728-732.
http://doi.org/10.1001/archpedi.1991.02160070025016.
- 15. French National Plan for Rare Diseases 2005-2008. (2004). Ensuring equity in the access to diagnosis,
treatment and provision of care. Erişim Tarihi: 18 Ocak 2018,
https://www.eurordis.org/IMG/pdf/EN_french_rare_disease_plan.pdf.
- 16. Gallo, A. M., Hadley, E. K., Angst, D. B., Knafl, K. A., Smith, C. A. (2008). Parents’ concerns about issues
related to their children's genetic conditions. Journal for Specialists in Pediatric Nursing, 13(1), 4-14.
https://doi.org/10.1111/j.1744-6155.2008.00129.x.
- 17. Global Genes Allies in Rare Diseases. (2017). Statistics and Figures on Prevalence of Genetic and Rare
Diseases. Erişim Tarihi: 21 Kasım 2017, https://globalgenes.org/rare-diseases-facts-statistics/.
- 18. Kirk, S., Glendinning, C. (2004). Developing services to support parents caring for a technologydependent
child at home. Child: Care, Health and Development, 30(3), 209-218.
https://doi.org/10.1111/j.1365-2214.2004.00393.x.
- 19. Kürtüncü Tanır, M., Kuğuoğlu S. (2006). Teknolojiye bağımlı çocuğun evde bakımı. Sürekli Tıp Eğitimi
Dergisi, 15(12) 214-8.
- 20. Lamb, C., Peden, A. (2008). Understanding the experience of living with spinal muscular atrophy: A
qualitative description. Journal of Neuroscience Nursing, 40, 250-256.
- 21. Lavandeira, A. (2002). Orphan drugs: Legal aspects, current situation. Haemophilia, 8(3), 194-198.
https://doi.org/10.1046/j.1365-2516.2002.00643.x.
- 22. Martinson, I.M., Liu-Chiang, C.Y., Yi-Hua, L. (1997). Distress symptoms and support systems of Chinese
parents of children with cancer. Cancer Nursing, 20, 94–99.
- 23. National Institutes of Health. (2017). Rare Diseases. Erişim tarihi 15 Kasım 2017,
https://medlineplus.gov/rarediseases.html.
- 24. Nunn, R. (2017). “It’s not all in my head!” - The complex relationship between rare diseases and mental
health problems. Orphanet Journal of Rare Diseases, 12, 29. http://doi.org/10.1186/s13023-017-0591-
7.
- 25. Orphanet Türkiye. (2017). Nadir hastalık nedir? Erişim Tarihi: 21 Kasım 2017,
http://www.orpha.net/national/TR-R/index/nadirhastal%C4%B1klarakk%C4%B1nda/.
- 26. Pelentsov, L. J., Fielder, A. L., Laws, T. A., Esterman, A. J. (2016). The supportive care needs of parents
with a child with a rare disease: results of an online survey. BMC Family Practice, 17(1),
http://doi.org/10.1186/s12875-016-0488-x.
- 27. Pelentsov, L. J., O'Shaughnessy, P. K., BHSc, Laws, T. A., Esterman, A. J. (2014). What are the supportive
care needs of parents caring for a child diagnosed with ectodermal dysplasia: A rare genetic disorder?
International Journal of Child Health and Human Development, 7(1), 23-29.
93
- 28. Pierucci, P., Lenato, G. M., Suppressa, P., Lastella, P., Triggiani, V., Valerio, R., ... Sabba, C. (2012). A
long diagnostic delay in patients with hereditary haemorrhagic telangiectasia: A questionnaire-based
retrospective study. Orphanet Journal of Rare Diseases, 7(1), 33. https://doi.org/10.1186/1750-1172-
7-33.
- 29. Ratcliffe, J., Longworth, L. (2002). Investigating the structural reliability of a discrete choice experiment
within health technology assessment. International Journal of Technology Assessment in Health Care,
18(1), 139-144.
- 30. Rode, J. (2005). Rare diseases: understanding this public health priority. EURORDIS: Paris, France. Erişim
Tarihi: 24 Şubat 2017, ttps://www.eurordis.org/IMG/pdf/princeps_document-EN.pdf.
- 31. Santos Luz, G. D., Silva, M. R. S. D., DeMontigny, F. (2016). Priority needs referred vy families of rare
disease patients. Texto & Contexto-Enfermagem, 25(4). e0590015. Epub November 28, 2016.
http://doi.org/10.1590/0104-07072016000590015.
- 32. Schieppati, A., Henter, J., Daina, E., Aperia, A. (2008). Why rare diseases are an important medical and
social issue. Lancet, 371 (9629), 2039–2041. https://doi.org/10.1016/S0140-6736(08)60872-7.
- 33. Shields, G., Schondel, C., Barnhart, L., Fitzpatrick, V., Sidell, N., Adams, P., Fertig, B., Gomez, S. (1995).
Social work in pediatric oncology: A family needs assessment. Social Work in Health Care, 21(1), 39-54.
https://doi.org/10.1300/J010v21n01_04.
- 34. Shire. (2013). Rare Disease Impact Report: Insights from Patients and The Medical Community. Erişim
Tarihi: 12.11.2018, https://globalgenes.org/wp-content/uploads/2013/04/ShireReport-1.pdf.
- 35. Somanadhan, S., Larkin, P. J. (2016). Parents’ experiences of living with, and caring for children,
adolescents and young adults with Mucopolysaccharidosis (MPS). Orphanet Journal of Rare
Diseases, 11, 138. http://doi.org/10.1186/s13023-016-0521-0.
- 36. Taruscio, D., Agresta, L., Amato, A., Bernardo, G., Bernardo, L., Braguti, F., … Vittozzi, L. (2014). The
Italian National Centre for Rare Diseases: Where research and public health translate into action. Blood
Transfusion, 12 (3), 591–605. http://doi.org/10.2450/2014.0040-14s.
- 37. Teague, B. R., Fleming, J. W., Castle, A., Kiernan, B. S., Lobo, M. L., Riggs, S., Wolfe, J. G. (1993). "High-
Tech" Home Care for Children With Chronic Health Conditions: A Pilot Study. Journal of Pediatric
Nursing, 8, 226-232.
- 38. Türkiye İstatistik Kurumu, (2016). İstatistiklerle Aile, Erişim tarihi: 10 Nisan 2017,
http://www.tuik.gov.tr/PreTablo.do?alt_id=1059.
- 39. Van der Zeijden, A., Huizer, J. (2010). Recommendations for the development of national plans for rare
diseases. Orphanet Journal of Rare Diseases, 5(1), O3. http://doi.org/10.1186/1750-1172-5-S1-O3.
- 40. Van Scheppingen, C., Lettinga, A. T., Duipmans, J. C., Maathuis, K. G., Jonkman, M. F. (2008). The main
problems of parents of a child with epidermolysis bullosa. Qualitative Health Research, 18(4), 545-556.
http://doi.org/10.1177/1049732308315110.
- 41. Yiu, J.M., Twinn, S. (2001). Determining the needs of Chinese parents during the hospitalization of their
child diagnosed with cancer: An exploratory study. Cancer Nursing, 24, 483-489.
94
- 42. Young, L., Creighton, D., Sauve, R. (1988) The needs of families of infants discharged home with
continuous oxygen therapy. Journal of Obstetric, Gynaecological and Neonatal Nursing, 17, 187–193.
https://doi.org/10.1111/j.1552-6909.1988.tb00424.x.
- 43. Youngblut, J., Brennan, P., Swegart, L. (1994). Families with medically fragile children: an exploratory
study. Pediatric Nursing, 20, 463-468.
- 44. Zurynski, Y., Deverell, M., Dalkeith, T., Johnson, S., Christodoulou, J., Leonard, H., Elliott, E. J. (2017).
Australian children living with rare diseases: experiences of diagnosis and perceived consequences of
diagnostic delays. Orphanet Journal of Rare Diseases, 12(1). http://doi.org/10.1186/s13023-017-0622-
4.